{"id":925587,"date":"2026-01-08T16:21:33","date_gmt":"2026-01-08T21:21:33","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/"},"modified":"2026-01-08T16:21:33","modified_gmt":"2026-01-08T21:21:33","slug":"vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/","title":{"rendered":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SOUTH SAN FRANCISCO, Jan.  08, 2026  (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (OTCQX: VXRT) (\u201cVaxart or \u201cthe Company\u201d), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies.<\/p>\n<p>\n        <strong>Presentation Details:<\/strong>\n      <\/p>\n<p>\n        <strong>Speakers: <\/strong>Steven Lo, Chief Executive Officer, Sean Tucker, Ph.D., Founder and Chief Scientific Officer, and James F. Cummings, M.D., Chief Medical Officer<br \/><strong>Date: <\/strong>Tuesday, January 13, 2026<br \/><strong>Time:\u00a0<\/strong>11:30am PT, 2:30pm ET<br \/><strong>Registration and Webcast: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=ddzaxFhGLP_Tw-lwqFfOyJdV_e7qZB8f_jopb3f_sZrFK78Frvx3pHPrEPWRZHpXPz5OLww-lXlFocicHW1qXPjS3kRpLm1X3B0BkVkZOq2b8L4WhigbGAq-Co8hjwFw\" rel=\"nofollow\" target=\"_blank\">Click Here<\/a><\/p>\n<p>The webcast will be available on the Company\u2019s investor relations website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=5LIntbWTT2tbX7dpsH9wuDFAicl2qSrc6M1QlJdYy6vJKDiA161nrevj2M5t2jXFzbuW9hGo9nXYbNqAXLUVpQxYR_yBz4agJYpVWjlG3FqSrPtyxxgG3qQhComjMYZW8qmbRjY8oIWZ45FEy9QszvPt1YGPcWyZ-05YQS6m2ObnLg1uwXYXlvUHILpMKWS0S7WgE2sJESF3n6F-CSyylQWti7YkftX_nkAdI3JM5_ndBy8CO-7C7ziWMPS5P6X4NhQ3S1HE7zFjxOExvgsTYmhxHps4EzU_KosJmZ7MTtvEfpnAsn1WyhlZw9XyNetA\" rel=\"nofollow\" target=\"_blank\">https:\/\/investors.vaxart.com<\/a> for 30 days following the conclusion of the event.<\/p>\n<p>\n        <strong>About Vaxart<br \/><\/strong>Vaxart is a clinical-stage biotechnology company developing a range of oral recombinant vaccines based on its proprietary delivery platform. Vaxart vaccines are designed to be administered using pills that can be stored and shipped without refrigeration and eliminate the risk of needle-stick injury. Vaxart believes that its proprietary pill vaccine delivery platform is suitable to deliver recombinant vaccines, positioning the company to develop oral versions of currently marketed vaccines and to design recombinant vaccines for new indications. Vaxart\u2019s development programs currently include pill vaccines designed to protect against coronavirus, norovirus and influenza, as well as a therapeutic vaccine for human papillomavirus (HPV), Vaxart\u2019s first immune-oncology indication. Vaxart has filed broad domestic and international patent applications covering its proprietary technology and creations for oral vaccination using adenovirus and TLR3 agonists.<\/p>\n<p>\n        <strong>Contact:<\/strong>\n      <\/p>\n<p>\n        <strong>Vaxart Media and Investor Relations<\/strong>:<br \/>FINN Partners<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gjrlz69Oi7KwVbvC32fUvb6mPx3lymrpyxz0lz1bHRU45SrD-ZbKHZSHgXwgzvUds5tdE7cwexZ3le3fMamN0w==\" rel=\"nofollow\" target=\"_blank\">IR@vaxart.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MWRkNTc0OGItNmIyOS00ODA3LTg1NWItM2E1OGIwNDdmYThjLTEwMzA2ODItMjAyNi0wMS0wOC1lbg==\/tiny\/Vaxart-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (OTCQX: VXRT) (\u201cVaxart or \u201cthe Company\u201d), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies. Presentation Details: Speakers: Steven Lo, Chief Executive Officer, Sean Tucker, Ph.D., Founder and Chief Scientific Officer, and James F. Cummings, M.D., Chief Medical OfficerDate: Tuesday, January 13, 2026Time:\u00a011:30am PT, 2:30pm ETRegistration and Webcast: Click Here The webcast will be available on the Company\u2019s investor relations website at\u00a0https:\/\/investors.vaxart.com for 30 days following the conclusion of the event. About VaxartVaxart &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-925587","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (OTCQX: VXRT) (\u201cVaxart or \u201cthe Company\u201d), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies. Presentation Details: Speakers: Steven Lo, Chief Executive Officer, Sean Tucker, Ph.D., Founder and Chief Scientific Officer, and James F. Cummings, M.D., Chief Medical OfficerDate: Tuesday, January 13, 2026Time:\u00a011:30am PT, 2:30pm ETRegistration and Webcast: Click Here The webcast will be available on the Company\u2019s investor relations website at\u00a0https:\/\/investors.vaxart.com for 30 days following the conclusion of the event. About VaxartVaxart &hellip; Continue reading &quot;Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-01-08T21:21:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026\",\"datePublished\":\"2026-01-08T21:21:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/\"},\"wordCount\":278,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/\",\"name\":\"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\",\"datePublished\":\"2026-01-08T21:21:33+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/","og_locale":"en_US","og_type":"article","og_title":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk","og_description":"SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) &#8212; Vaxart, Inc. (OTCQX: VXRT) (\u201cVaxart or \u201cthe Company\u201d), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it will participate in the Global BioInnovation Forum, a virtual gathering of senior leaders building and scaling next-generation life science and health innovation companies. Presentation Details: Speakers: Steven Lo, Chief Executive Officer, Sean Tucker, Ph.D., Founder and Chief Scientific Officer, and James F. Cummings, M.D., Chief Medical OfficerDate: Tuesday, January 13, 2026Time:\u00a011:30am PT, 2:30pm ETRegistration and Webcast: Click Here The webcast will be available on the Company\u2019s investor relations website at\u00a0https:\/\/investors.vaxart.com for 30 days following the conclusion of the event. About VaxartVaxart &hellip; Continue reading \"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/","og_site_name":"Market Newsdesk","article_published_time":"2026-01-08T21:21:33+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026","datePublished":"2026-01-08T21:21:33+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/"},"wordCount":278,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/","name":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=","datePublished":"2026-01-08T21:21:33+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTYyMjU2MyM3MzUyMTk0IzIwMTkxMDk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/vaxart-to-participate-in-the-global-bioinnovation-forum-on-january-13-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925587","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=925587"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/925587\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=925587"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=925587"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=925587"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}